Objective-To investigate the influence of breast feeding, use of the oral contraceptive pill (OCP), and parity on rheumatoid arthritis (RA). Methods-One hundred and seventy six women with RA were compared with 145 control subjects; all had at least one child. RA patients were classified as having severe (n = 82) or mild disease (n = 89) according to clinical joint evaluation, radiological score, biological inflammation, and the presence of HLA-DR1 or -DR4 alleles. Results-The mean age ofRA patients was 58 years, and the mean age at the time of diagnosis of RA was 46 years. The mean time between onset of RA and the first birth was 23-6 (SD 3.8) years. The OCP user rates were 33% in the RA group and 47-6% in the control group (p < 0.02). OCP use was related to the mother's year of birth. The relative risk for developing RA was 0-598 (95% confidence interval (CI) 0-33 to 1
use was related to the mother's year of birth. The relative risk for developing RA was 0-598 (95% confidence interval (CI) 0-33 to 1.1) in women who had used OCP for more than five years compared with those who had never used OCPs. In contrast, the age at which the first pregnancy occurred, the number of children breast fed, and the duration of breast feeding were comparable in RA patients and healthy subjects. Among the RA patients, parity, duration ofbreast feeding, and the number ofbreast fed children were significandy increased in those with severe disease. Having more than three children increased the risk of developing severe disease 4-8-fold when adjusted for age and OCP use. Forty six percent of women with severe RA had a history of breast feeding duration greater than six months before disease onset, compared with 26% of patients with mild disease (p < 0.008).
Having more than three breast fed children increased the risk of poor disease prognosis 3-7-fold. In contrast, OCP use had a protective role in the course We excluded six women in whom their first birth occurred after RA onset. In the control group (n = 145), the response rate was 74%. Values are % or mean (SD). RF = Rheumatoid factor; ESR = erythrocyte sedimentation rate; CRP = C reactive protein. (19) 24-4 (4-3) 54 (37) 41 (28) 29 (20) 21 (15) 57 (40) 42 (29) 44 (31) Values are mean (SD) or t number (%). OCP = Oral contraceptive pill. tOdds ratios adjusted for age at birth, parity, and breast feeding, using logistic regression analysis.
We did not note any difference in parity, number of breast fed children, and total duration of breast feeding between RA patients and controls. We were not able to study the effect of nulliparity because all women selected had had at least one live birth. Values are mean (SD) or t number (%). 0-07 (0-01 to 0-29) 0-1 (0-01 to 0-6) tOdds ratios adjusted for age at birth, parity, and breast feeding using logistic regression analysis. (11) years v 55-6 (12-5); p < 0 002). Table 5 shows that the protective effect of OCP remained after adjustment for age and parity (OR = 0 1, 95% CI 0-01 to 0-6) with OCP use of more than five years.
Parity and RA severity Having had two children increased the risk of severe disease twofold, and with three or more children there was a 5*75-fold increased risk of poor prognosis of RA (p < 0000 1). These results remained significant when adjusted for age, OCP use, and breast feeding (table 6 ). Age at the first birth and the mean time between the first birth and onset of the disease did not modify the course of the disease in our study (table 4) .
Breastfeeding and RA severity The mean duration of breast feeding was increased in the RA group with severe disease, with an effect of duration: 46% of women with severe RA had a history of total breast feeding duration of more than six months, compared with 26% of those with mild RA (p<002). A history of breast feeding of more than six months increased the risk of severe RA twofold, but this was not significant after adjustment for age, parity, and OCP use (table 7) . In addition, the number of breast fed children was greater in women with severe RA compared with mild disease (29% v 9% respectively; p < 0-008). The relative risk of severe RA with three or more breast fed children before RA onset was increased 1A4-fold (table 7) .
Discussion
The results of the present study confirm the protective effect of OCP on the disease course of RA and suggest a decreased risk of developing RA among OCP users. Our results showed further that parity increased the risk of severe RA independently of OCP use and breast feeding before RA onset. In contrast, breast feeding was a confounding factor, but did not alter the course of the disease when adjusted for age or parity. There were possible sources of bias in this study. The quality of the data collected could be questioned, as they were obtained through subject recall, and recall bias might have differed for controls and RA patients. However, random error in the exposure data, if present, would have led to dilution of any observed effect, and would not have modified the results. In addition, the two groups had similar questionnaire response rates. The control group selected from the breast cancer screening programme was chosen on the basis that it was representative of the local population. There are two concerns here: first, those that respond to an invitation to attend for screening may not be representative of the underlying population, and second, only 75% of those who attended for screening responded to the questionnaire for this study. It is thus very likely that the control groups studied might not have been representative in respect of their contraceptive, pregnancy, and breast feeding history. Unfortunately, we have no data on which to assess these issues and thus cannot exclude the possibility that the differences observed between the study and control groups may be explained, at least in part, by our method of selection of the controls. suggest that having had more than three children did not modify the risk of developing RA, but increased the risk of poor disease prognosis 4*8-fold. Multiparity was associated with more severe disease in past studies.' We were not able to study the incidence of nulliparity on RA, because we selected women who had at least one child.
After a dramatic RA response during pregnancy, postpartum relapse occurs in more than 90% of patients within six months after they give birth.3 24 25 It seems that the timing of postpartum relapse is not correlated with lactation.2 In addition, pregnancy occurring before the disease onset decreases the risk of developing RA.8 However, the effect of breast feeding on the disease course has never been studied. Recently, a Norwegian study has shown a protective effect of lactation on RA development, but this work was limited by the use of the death certificate as the source for the diagnosis.26 Our results suggested that breast feeding did not increase the risk of developing RA: duration of breast feeding was significantly related to severe RA but, when adjusted for age and parity, a history of lactation before disease onset did not alter the course of the disease. In contrast, an increased incidence of the relative risk of developing RA in the postpartum period has been reported, particularly for severe and erosive disease.7 One explanation for the possible effect ofbreast feeding on the development and course of RA might be a persistent increase in serum concentrations of prolactin during lactation. This hormone has an immunostimulant effect in vitro, and lymphocytes have been shown to express prolactin receptors. Moreover, in animal models of arthritis, arthritis improved after hypophysectomy or prolactin antagonist administration, and arthritis could be restored after prolactin injection.9 Postpartum flare up of collagen induced arthritis decreased after administration of bromocriptine.'0 In RA, secretion of prolactin was shown to be upregulated, and excessively increased in case of stress.27 During pregnancy, immunosuppressive factors might explain the improvement in RA. 28 29 Our results provide evidence that parity and previous OCP use modify the course of RA, but breast feeding seems to be a dependent effect. The underlying mechanisms are unknown, but our data should stimulate further research in the field of immunoendocrinology.
